Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up.
Jordan
M L
ML
Division of Urologic Surgery/Transplantation, University of Pittsburgh Medical Center, PA 15213, USA.
Shapiro
R
R
Vivas
C
C
Scantlebury
V
V
McCauley
J
J
McMichael
J
J
Randhawa
P
P
Demetris
A
A
Fung
J
J
Starzl
T E
TE
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000145:classification / Q000188:drug therapy* / Q000473:pathology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus